These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

705 related articles for article (PubMed ID: 12502447)

  • 1. [Portosystemic shunt via the left branch of portal vein for the prevention of encephalopathy following transjugular intrahepatic portosystemic shunt].
    Chu J; Sun X; Piao L; Chen Z; Huang H; Lu C; Xu J
    Zhonghua Gan Zang Bing Za Zhi; 2002 Dec; 10(6):437-40. PubMed ID: 12502447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes of transjugular intrahepatic portosystemic shunt through the left branch vs. the right branch of the portal vein in advanced cirrhosis: a randomized trial.
    Chen L; Xiao T; Chen W; Long Q; Li R; Fang D; Wang R
    Liver Int; 2009 Aug; 29(7):1101-9. PubMed ID: 19386025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted puncture of left branch of intrahepatic portal vein in transjugular intrahepatic portosystemic shunt to reduce hepatic encephalopathy.
    Luo SH; Chu JG; Huang H; Zhao GR; Yao KC
    World J Gastroenterol; 2019 Mar; 25(9):1088-1099. PubMed ID: 30862997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Transjugular intrahepatic portosystemic shunt and combination with percutaneous transhepatic or transsplenic approach for the treatment of portal vein thrombosis with or without cavernomatous transformation].
    Han GH; Meng XJ; Yin ZX; Wang JH; He CY; Liang J; Guo XG; Liu J; Ding L; Wu KC; Fan DM
    Zhonghua Yi Xue Za Zhi; 2009 Jun; 89(22):1549-52. PubMed ID: 19953883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Helicobacter pylori infection does not correlate with plasma ammonia concentration and hepatic encephalopathy in patients with cirrhosis.
    Huber M; Rössle M; Siegerstetter V; Ochs A; Haag K; Kist M; Blum HE
    Hepatogastroenterology; 2001; 48(38):541-4. PubMed ID: 11379349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of percutaneous intrahepatic portosystemic shunt on splanchnic and systemic hemodynamics in patients with portal hypertension].
    François E; García-Pagán JC; Bru C; Feu F; Gilabert R; Escorsell A; Bosch J; Rodés J
    Gastroenterol Hepatol; 1997 Jan; 20(1):1-4. PubMed ID: 9072189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Portosystemic hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in patients with cirrhosis: clinical, laboratory, psychometric, and electroencephalographic investigations.
    Nolte W; Wiltfang J; Schindler C; Münke H; Unterberg K; Zumhasch U; Figulla HR; Werner G; Hartmann H; Ramadori G
    Hepatology; 1998 Nov; 28(5):1215-25. PubMed ID: 9794904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transjugular intrahepatic portosystemic shunt (TIPS) in the treatment of venous symptomatic chronic portal thrombosis in non-cirrhotic patients.
    Bilbao JI; Elorz M; Vivas I; Martínez-Cuesta A; Bastarrika G; Benito A
    Cardiovasc Intervent Radiol; 2004; 27(5):474-80. PubMed ID: 15383850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of transjugular intrahepatic portosystemic shunt induced refractory hepatic encephalopathy with the parallel technique: results of a clinical follow-up study.
    Maleux G; Heye S; Verslype C; Nevens F
    J Vasc Interv Radiol; 2007 Aug; 18(8):986-92; quiz 993. PubMed ID: 17675616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation.
    Testino G; Ferro C; Sumberaz A; Messa P; Morelli N; Guadagni B; Ardizzone G; Valente U
    Hepatogastroenterology; 2003; 50(54):1753-5. PubMed ID: 14696397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of shunting left/right portal vein branch on post-TIPS hepatic encephalopathy: a study protocol for multicenter randomized blinded controlled trial.
    Ma J; Luo J; Zhang W; Zhou Y; Zhang Z; Yang M; Zhuang Z; Ma L; Yu J; Zhou X; Yan Z
    Trials; 2023 May; 24(1):312. PubMed ID: 37149647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transjugular intrahepatic portosystemic shunt placement in patients with cirrhosis and concomitant portal vein thrombosis.
    Van Ha TG; Hodge J; Funaki B; Lorenz J; Rosenblum J; Straus C; Leef J
    Cardiovasc Intervent Radiol; 2006; 29(5):785-90. PubMed ID: 16850140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The transjugular intrahepatic portosystemic stent-shunt (TIPS) as rescue therapy for complete Budd-Chiari syndrome and portal vein thrombosis.
    Opitz T; Buchwald AB; Lorf T; Awuah D; Ramadori G; Nolte W
    Z Gastroenterol; 2003 May; 41(5):413-8. PubMed ID: 12772054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical outcomes of transcatheter selective superior mesenteric artery urokinase infusion therapy
    Jiang TT; Luo XP; Sun JM; Gao J
    World J Gastroenterol; 2017 Nov; 23(41):7470-7477. PubMed ID: 29151701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transjugular intrahepatic portosystemic shunts in hemodialysis-dependent patients and patients with advanced renal insufficiency: safety, caution, and encephalopathy.
    Haskal ZJ; Radhakrishnan J
    J Vasc Interv Radiol; 2008 Apr; 19(4):516-20. PubMed ID: 18375295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct puncture of the recanalized paraumbilical vein for portal vein targeting during transjugular intrahepatic portosystemic shunt procedures: assessment of technical success and safety.
    Chin MS; Stavas JM; Burke CT; Dixon RG; Mauro MA
    J Vasc Interv Radiol; 2010 May; 21(5):671-6. PubMed ID: 20430297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of different portal vein branches on hepatic encephalopathy during intrahepatic portal shunt
    Yao X; He S; Wei M; Qin JP
    World J Gastroenterol; 2022 Aug; 28(31):4467-4470. PubMed ID: 36159008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Portal flow and arterioportal shunting after transjugular intrahepatic portosystemic shunt creation.
    Itkin M; Trerotola SO; Stavropoulos SW; Patel A; Mondschein JI; Soulen MC; Tuite CM; Shlansky-Goldberg RD; Faust TW; Reddy KR; Solomon JA; Clark TW
    J Vasc Interv Radiol; 2006 Jan; 17(1):55-62. PubMed ID: 16415133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of transjugular intrahepatic portosystemic shunt for variceal bleeding in hepatocellular carcinoma patients with portal vein thrombosis].
    Chung WJ; Jang BK; Park KS; Cho KB; Hwang JS; Ahn SH; Kim YH; Kim YH; Kim YJ
    Korean J Hepatol; 2005 Jun; 11(2):157-63. PubMed ID: 15980674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TIPS in patients with cranial porta hepatis: ultrasound-guided transhepatic portohepatic-portocaval puncture in single needle pass.
    Liang HL; Liu WC; Huang JS; Chen MC; Lai KH; Pan HB; Chen CK
    AJR Am J Roentgenol; 2011 Apr; 196(4):914-8. PubMed ID: 21427345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.